Dying From COVID-19: Loneliness, End-of-Life Discussions, and Support for Patients and Their Families in Nursing Homes and Hospitals. A National Register Study.


Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
10 2020
Historique:
received: 09 06 2020
revised: 17 07 2020
accepted: 18 07 2020
pubmed: 30 7 2020
medline: 3 10 2020
entrez: 30 7 2020
Statut: ppublish

Résumé

Preparation for an impending death through end-of-life (EOL) discussions and human presence when a person is dying is important for both patients and families. The aim was to study whether EOL discussions were offered and to what degree patients were alone at time of death when dying from coronavirus disease 2019 (COVID-19), comparing deaths in nursing homes and hospitals. The national Swedish Register of Palliative Care was used. All expected deaths from COVID-19 in nursing homes and hospitals were compared with, and contrasted to, deaths in a reference population (deaths in 2019). A total of 1346 expected COVID-19 deaths in nursing homes (n = 908) and hospitals (n = 438) were analyzed. Those who died were of a more advanced age in nursing homes (mean 86.4 years) and of a lower age in hospitals (mean 80.7 years) (P < 0.0001). Fewer EOL discussions with patients were held compared with deaths in 2019 (74% vs. 79%, P < 0.001), and dying with someone present was much more uncommon (59% vs. 83%, P < 0.0001). In comparisons between nursing homes and hospital deaths, more patients dying in nursing homes were women (56% vs. 37%, P < 0.0001), and significantly fewer had a retained ability to express their will during the last week of life (54% vs. 89%, P < 0.0001). Relatives were present at time of death in only 13% and 24% of the cases in nursing homes and hospitals, respectively (P < 0.001). The corresponding figures for staff were 52% and 38% (P < 0.0001). Dying from COVID-19 negatively affects the possibility of holding an EOL discussion and the chances of dying with someone present. This has considerable social and existential consequences for both patients and families.

Identifiants

pubmed: 32721500
pii: S0885-3924(20)30630-8
doi: 10.1016/j.jpainsymman.2020.07.020
pmc: PMC7382350
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2-e13

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Intensive Crit Care Nurs. 2020 Jun;58:102862
pubmed: 32280052
J Clin Oncol. 2011 Oct 10;29(29):3927-31
pubmed: 21911715
Palliat Med. 2012 Jun;26(4):313-21
pubmed: 21737480
J Pain Symptom Manage. 2019 Apr;57(4):746-752
pubmed: 30639732
Am J Geriatr Psychiatry. 2016 Apr;24(4):261-71
pubmed: 26976293
Am J Hosp Palliat Care. 2012 Dec;29(8):632-9
pubmed: 22363039
J Pain Symptom Manage. 2020 Feb;59(2):187-196
pubmed: 31539600
BMJ. 2020 Apr 15;369:m1472
pubmed: 32295758
J Pain Symptom Manage. 2010 Jan;39(1):9-22
pubmed: 19782530
Epidemiology. 2007 Nov;18(6):805-35
pubmed: 18049195
Palliat Med. 2018 Sep;32(8):1305-1321
pubmed: 29956558
Eur J Cancer Care (Engl). 2018 Jan;27(1):
pubmed: 28727207
Psychooncology. 2012 Aug;21(8):868-76
pubmed: 21648015
PLoS One. 2017 Oct 19;12(10):e0186804
pubmed: 29049396
N Engl J Med. 2020 Jun 11;382(24):e88
pubmed: 32289215
J Palliat Med. 2006 Dec;9(6):1376-87
pubmed: 17187546
JAMA Intern Med. 2018 Jul 1;178(7):930-940
pubmed: 29802770
BMC Palliat Care. 2020 Mar 24;19(1):37
pubmed: 32209075
J Palliat Med. 2006 Dec;9(6):1359-68
pubmed: 17187544
Death Stud. 2019;43(8):509-520
pubmed: 30207512
Palliat Support Care. 2007 Jun;5(2):153-9
pubmed: 17578066
Omega (Westport). 2012-2013;66(3):231-63
pubmed: 23617101

Auteurs

Peter Strang (P)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; R & D Department, Stockholms Sjukhem Foundation, Stockholm, Sweden. Electronic address: peter.strang@ki.se.

Jonas Bergström (J)

Palliative Care Unit, Stockholms Sjukhem Foundation, Stockholm, Sweden.

Lisa Martinsson (L)

Department of Radiation Sciences, Umeå University, Umeå, Sweden.

Staffan Lundström (S)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; R & D Department, Stockholms Sjukhem Foundation, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH